# ATAZANAVIR SULFATE
> **ANDA209717** · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2020-06-01
## Drug
- **FDA Application Number:** ANDA209717
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ATAZANAVIR SULFATE
- **Generic name:** Atazanavir Sulfate
- **Active ingredients:** ATAZANAVIR SULFATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** AMNEAL
- **First approval:** 2020-06-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209717)
---
*AI Analytics · CC0 1.0*